Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
4.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

535
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
535
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

18.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.6K
Optimal Foraging00:48

Optimal Foraging

13.8K
How animals obtain and eat their food is called foraging behavior. Foraging can include searching for plants and hunting for prey and depends on the species and environment.
13.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A near-infrared fluorescent probe lights up protective carbon monoxide during inflammation in live systems.

Analytica chimica acta·2026
Same author

A BBB-permeable β<sub>3</sub>-AR probe enables redox imaging, natural inhibitors discovery, and therapeutic monitoring in glioblastoma.

Science advances·2026
Same author

Synthesis and evaluation of 5-phenoxylmethyl-1,3,4-oxadiazol-2-ones/oxadiazole-2-thiones as potent urease inhibitors.

Bioorganic & medicinal chemistry·2026
Same author

Visualization of Stress-Induced Dynamic Ethylene in AOX1A Transgenic Using a Fluorescent Lifetime Probe.

Analytical chemistry·2026
Same author

Ultra-large stokes shift probe enables SIM super-resolution tracking of lysosomal acidification impairment in Aβ trafficking dysregulation during Alzheimer's disease.

Biosensors & bioelectronics·2025
Same author

Design, synthesis, and biological evaluation of 2-(benzylthio)-5-(indol-3-yl)-1,3,4-oxadiazole derivatives as tubulin polymerization inhibitors with potential anti-cancer effects.

European journal of medicinal chemistry·2025

Related Experiment Video

Updated: Feb 1, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.3K

Optimization techniques for novel c-Met kinase inhibitors.

Zhi-Gang Sun1,2, Yong-An Yang2, Zhi-Gang Zhang3

  • 1a Central Laboratory , Linyi Central Hospital , Linyi , China.

Expert Opinion on Drug Discovery
|December 7, 2018
PubMed
Summary

Novel c-Met kinase inhibitors are crucial for cancer treatment, targeting cell growth and survival. Structural optimization and the

Keywords:
Cancerc-Methepatocyte growth factorinhibitorsoptimization

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.6K
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.9K

Related Experiment Videos

Last Updated: Feb 1, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.3K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.6K
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.9K

Area of Science:

  • Oncology and Medicinal Chemistry

Background:

  • c-Met kinase is a key regulator of cell growth, invasion, and apoptosis.
  • It represents a significant therapeutic target in cancer treatment.

Purpose of the Study:

  • To review recent advancements in the synthesis, optimization, and structure-activity relationships (SAR) of novel c-Met kinase inhibitors.
  • To highlight the role of specific structural motifs, such as the '5-atoms linker', in inhibitor design.

Main Methods:

  • Review of recent scientific literature on c-Met inhibitors.
  • Analysis of structure-activity relationships (SAR) for novel small molecule inhibitors.
  • Examination of drugs currently on the market and in clinical trials.

Main Results:

  • Numerous novel c-Met kinase inhibitors have been developed through structural optimization and SAR studies.
  • The '5-atoms linker' has been identified as a critical component in the design of effective c-Met inhibitors.
  • Progress in small molecule inhibitor research is detailed.

Conclusions:

  • Structural optimization remains key to developing improved c-Met kinase inhibitors.
  • Exploring natural product chemistry offers a potential new avenue for discovering novel c-Met inhibitors.